Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis

Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A... Oncol Ther (2018) 6:73–85 https://doi.org/10.1007/s40487-018-0059-5 ORIGINAL RESEARCH Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician– Patient Real-World Clinical Data Analysis . . . . Tony Lough Qingyang Luo Paul O’Sullivan Christophe Chemasle ´ . . Michael Stotzer James Suttie David Darling Received: February 15, 2018 / Published online: April 19, 2018 The Author(s) 2018 physicians who each evaluated the same real- ABSTRACT world clinical case data for 30 patients under- going surveillance for recurrent UC. Each Introduction: International guidelines advo- physician ordered tests and procedures and cate regular surveillance of patients following their timing, following review of the patient’s urothelial carcinoma (UC). A validated molec- demographic data, pre-existing conditions, risk ular diagnostic non-invasive urine test, factors and clinical history before and after Cxbladder Monitor, correctly identifies patients disclosure of Cxbladder Monitor results. Chan- with a UC history who have low-probability of ges in the number, type and timing of proce- recurrence. The present study assesses the clin- dures ordered were assessed. ical utility of Cxbladder Monitor in reducing Results: The addition of Cxbladder Monitor the number and frequency of urologic proce- significantly reduced the overall number of tests dures ordered without missing http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis

Loading next page...
 
/lp/springer-journals/clinical-utility-of-cxbladder-monitor-for-patients-with-a-history-of-uar2UH6yWG
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-018-0059-5
Publisher site
See Article on Publisher Site

Abstract

Oncol Ther (2018) 6:73–85 https://doi.org/10.1007/s40487-018-0059-5 ORIGINAL RESEARCH Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician– Patient Real-World Clinical Data Analysis . . . . Tony Lough Qingyang Luo Paul O’Sullivan Christophe Chemasle ´ . . Michael Stotzer James Suttie David Darling Received: February 15, 2018 / Published online: April 19, 2018 The Author(s) 2018 physicians who each evaluated the same real- ABSTRACT world clinical case data for 30 patients under- going surveillance for recurrent UC. Each Introduction: International guidelines advo- physician ordered tests and procedures and cate regular surveillance of patients following their timing, following review of the patient’s urothelial carcinoma (UC). A validated molec- demographic data, pre-existing conditions, risk ular diagnostic non-invasive urine test, factors and clinical history before and after Cxbladder Monitor, correctly identifies patients disclosure of Cxbladder Monitor results. Chan- with a UC history who have low-probability of ges in the number, type and timing of proce- recurrence. The present study assesses the clin- dures ordered were assessed. ical utility of Cxbladder Monitor in reducing Results: The addition of Cxbladder Monitor the number and frequency of urologic proce- significantly reduced the overall number of tests dures ordered without missing

Journal

Oncology and TherapySpringer Journals

Published: Apr 19, 2018

References